B Cell Panel

3 biomarkers Sample: Blood Peer-reviewed

Biomarkers in this category

3 biomarkers · optimal ranges shown

Naive B cells CD19+CD27-CD21-CD38- are a specific subset of B cells with distinct surface marker characteristics: CD19+: This marker indicates that these cells express the CD19 antigen, which is commonly found on B cells. CD27-: The absence of CD27 expression suggests that these B cells are not memory B cells. CD27 is typically expressed on memory B cells. CD21-: The absence of CD21 expression may indicate that these B cells have reduced levels of complement receptor 2 (CR2), which can affect their ability to respond to complement-mediated signals. CD38-: The absence of CD38 expression suggests that these B cells have lower levels of CD38, which is involved in various B cell functions, including activation and differentiation. The term "naive" implies that these B cells have not yet encountered and been activated by antigens. They are considered to be in an immature state and are ready to respond to new antigens when encountered. The term "(% Pos of B)" likely refers to the percentage of these naive B cells within the total population of B cells in a given sample or context. The exact percentage can vary depending on the individual and the specific experimental conditions.

CD19+CD27+IgM+IgD+ refers to a specific subset of B cells characterized by the expression of the cell surface markers CD19, CD27, IgM, and IgD. These markers help categorize B cells into different subsets based on their developmental stage and function. In this context, the percentage of CD19+CD27+IgM+IgD+ cells (% of CD27+) likely refers to the proportion of B cells with this specific phenotype within the total CD27+ B cell population. It represents a subset of memory B cells with unique characteristics. Research suggests that CD27+IgD+ B cells, also known as IgM memory B cells, are distinct from other B cell subsets and may play a role in immune responses. They have been associated with certain conditions, such as common variable immunodeficiency (CVID), where their levels may be altered compared to healthy individuals. The exact percentage can vary among individuals and may have implications for understanding immune function and response in different contexts. However, the specific percentage may not be provided in the provided search results. To determine the exact percentage, laboratory testing or research studies would be needed. Naive B cells, specifically CD19+CD27+IgM+IgD+ B cells, represent a subset of B lymphocytes in the immune system. Here's more details on the different populations: CD27 Expression: CD27 is a cell surface marker used to distinguish between different B cell populations. In humans, CD27 expression helps differentiate between memory and naive B cells. Naive B cells typically have low levels of CD27 expression, while memory B cells have higher levels. IgM and IgD Expression: CD19+CD27+IgM+IgD+ indicates that these B cells express both IgM and IgD immunoglobulins, which are antigen receptors on B cells. This expression pattern is characteristic of naive or less-differentiated B cells. Percentage of CD27+: The term "CD19+CD27+IgM+IgD+ (% of CD27+)" suggests that you are looking for the proportion of CD27+ B cells that express CD19, IgM, and IgD. This percentage would represent the subset of CD27+ B cells that exhibit the naive B cell phenotype. Naive B cells with the CD19+CD27+IgM+IgD+ phenotype are a subset of B cells with low CD27 expression and the presence of both IgM and IgD. The percentage of these cells within the CD27+ B cell population may vary depending on the individual and their immune status, but they are typically considered less differentiated and play a role in the initial immune response to new antigens.